Filing Details

Accession Number:
0001140361-13-034298
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-27 15:41:31
Reporting Period:
2013-08-23
Filing Date:
2013-08-27
Accepted Time:
2013-08-27 15:41:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
275053 Natures Sunshine Products Inc NATR Pharmaceutical Preparations (2834) 870327982
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1459276 Jamon Jarvis 75 East 1700 South
Provo UT 84606
Evp, Gen Counsel, Sec, Cco No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-08-23 700 $7.38 700 No 4 M Direct
Common Stock Disposition 2013-08-23 700 $18.17 0 No 4 S Direct
Common Stock Acquisiton 2013-08-26 5,044 $7.38 5,044 No 4 M Direct
Common Stock Acquisiton 2013-08-26 153 $9.87 5,197 No 4 M Direct
Common Stock Disposition 2013-08-26 5,197 $18.10 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2013-08-23 700 $0.00 700 $7.38
Common Stock Employee Stock Option (Right to Buy) Disposition 2013-08-26 5,044 $0.00 5,044 $7.38
Common Stock Employee Stock Option (Right to Buy) Disposition 2013-08-26 153 $0.00 153 $9.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,044 2021-01-03 No 4 M Direct
0 2021-01-03 No 4 M Direct
41,847 2020-05-10 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.10 to $18.23, inclusive. The reporting person undertakes to provide Nature's Sunshine Products, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
  2. On August 8, 2013, the Issuer declared a one-time cash dividend of $1.50 per share to shareholders of record as of August 19, 2013, to be paid on August 29, 2013. As a result, pursuant to anti-dilution provisions of the Issuer's stock incentive plans, the exercise price of all outstanding options were reduced by $1.50.
  3. The option vests in three equal installments based on satisfaction of certain performance criteria. The performance criteria for 2/3 of the options were determined to have been met on 3/1/12, resulting in vesting of the option with respect to 20,000 shares. The remainder of the option vested with respect to 10,000 shares on 8/21/12 when the performance criteria for the final 1/3 of the option were determined to have been met.
  4. On May 10, 2010, the reporting person was granted an option to purchase 42,000 shares of common stock. The option vests in three equal installments based on satisfaction of certain performance criteria. The performance criteria for two-thirds of the options were determined to have been met on 3/1/12, resulting in vesting of the option with respect to 28,000 shares. The remainder of the option vested with respect to 14,000 shares on 8/21/12 when the performance criteria for the final one-third of the options were determined to have been met.